Literature DB >> 10863118

Coma and respiratory depression following the ingestion of GHB and its precursors: three cases.

M Ingels1, C Rangan, J Bellezzo, R F Clark.   

Abstract

Gamma hydroxybutyrate (GHB) is a product of the metabolism of both gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Gamma hydroxybutyrate (GHB) is an illegal agent that causes central nervous system depression. Chemical precursors of GHB, such as GBL and 1,4-BD, have been available for purchase from many health food stores and Internet websites for mood-enhancement, sleep-induction, and stimulation of growth hormone release. We report three cases of ingestion of products containing GHB and chemical precursors of GHB. All three patients had severe presentations followed by full recoveries. Some products containing GBL were withdrawn from the market after the FDA issued a warning regarding these products. Products containing 1,4-butanediol remain on the market today.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863118     DOI: 10.1016/s0736-4679(00)00188-8

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  10 in total

1.  Traumatic brain injury after a motor vehicle accident: fact or "fantasy"?

Authors:  D G Caldicott; N Edwards
Journal:  Emerg Med J       Date:  2001-11       Impact factor: 2.740

2.  Gamma-hydroxybutyrate and ethanol effects and interactions in humans.

Authors:  Dung Thai; Jo Ellen Dyer; Neal L Benowitz; Christine A Haller
Journal:  J Clin Psychopharmacol       Date:  2006-10       Impact factor: 3.153

Review 3.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

4.  Preference for gamma-hydroxybutyrate (GHB) in current users.

Authors:  John M Roll; Thomas Newton; Joy Chudzynski; Jennifer M Cameron; Sterling McPherson; Timothy Fong; Matt Torrington
Journal:  J Exp Anal Behav       Date:  2012-05       Impact factor: 2.468

5.  The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion.

Authors:  Paul I Dargan; Jenny Button; Susie Davies; John Ramsey; Simi George; David W Holt; David M Wood
Journal:  J R Soc Med       Date:  2009-12       Impact factor: 5.344

6.  [gamma-Hydroxybutyrate intoxication].

Authors:  N Hahne; W Weinmann; B W Nebel
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

7.  Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.

Authors:  Amy K Goodwin; Barbara J Kaminski; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2012-09-04       Impact factor: 4.530

8.  Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.

Authors:  A K Goodwin; P R Brown; E E W Jansen; C Jakobs; K M Gibson; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2009-02-06       Impact factor: 4.530

Review 9.  Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.

Authors:  Enrico Marinelli; Renata Beck; Antonio Malvasi; Alfredo Fabrizio Lo Faro; Simona Zaami
Journal:  Arh Hig Rada Toksikol       Date:  2020-03-01       Impact factor: 1.948

Review 10.  Toxicological Characterization of GHB as a Performance-Enhancing Drug.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.